Influencing care in acute myocardial infarction: A randomized trial comparing 2 types of intervention

American Journal of Medical Quality

Volumn 15, Issue 5, 2000, Pages 197-206

  Sauaia, Angela ^a   Ralston, Debra ^a   Schluter, W William ^a   Marciniak, Thomas A ^a,b   Havranek, Edward P ^a,c,d   Dunn, Thomas R ^a,d  

^a Colorado Foundation for Medical Care ^*  (United States)

^b CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Medicare; Myocardial infarction; Quality of care; Randomized trial

Indexed keywords

AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION; FEEDBACK SYSTEM; FEMALE; GOVERNMENT; HEALTH CARE QUALITY; HEART INFARCTION; HOSPITAL ADMINISTRATOR; HUMAN; MALE; MEDICAL EDUCATION; MEDICAL STAFF; MEDICARE; MORTALITY; ORGANIZATION AND MANAGEMENT; RANDOMIZED CONTROLLED TRIAL; STANDARD; TREATMENT OUTCOME; UNITED STATES;

AGED; ANALYSIS OF VARIANCE; COLORADO; EDUCATION, MEDICAL, CONTINUING; FEEDBACK; FEMALE; HOSPITAL ADMINISTRATORS; HUMANS; MALE; MEDICAL STAFF, HOSPITAL; MEDICARE; MYOCARDIAL INFARCTION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 0034263463     PISSN: 10628606     EISSN: None     Source Type: Journal    
DOI: 10.1177/106286060001500503     Document Type: Article

References (36)

1. US Bureau of the Census. Statistical Abstract of the United States: 1997. 117th ed. Washington, DC; 1997.
2. Hennekens CH, Buring JE, Sandercock P, et al. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation. 1989;80:749-756.
3. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative metaanalysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248-254.
4. Fuster V, Dyken ML, Vokonas PS, et al. Aspirin as a therapeutic agent in cardiovascular disease. Circulation. 1993;87:659-675.
5. Collins R, Peto R, Baigentt C, et al. Aspirin, heparin, and fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 1997;336:847-860.
6. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996;28:1328-1419.
7. Lamas GA, Pfeffer MA, Hamm P, et al. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med. 1992;327:241-247.
8. Hennekens CH, Jonas MA, Buring JE. The benefits of aspirin in acute myocardial infarction: still a well-kept secret in United States. Arch Intern Med. 1994;154:37-39.
9. Col NF, McLaughlin TJ, Soumerai SB, et al. The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study. Arch Intern Med. 1996;156:54-60.
10. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996;156:799-805.
11. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the cooperative cardiovascular project. JAMA. 1995;273:1509-1514.
12. Krumholz HM, Murillo JE, Chen J, et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA. 1997;277:1683-1688.
13. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the cooperative cardiovascular project JAMA. 1998;279:1351-1357.
14. Krumholz HM, Friesinger GC, Cook F, et al. Relationship of age with eligibility for thrombolytic therapy and mortality among patients with suspected acute myocardial infarction. J Am Geriatr Soc. 1994;42:127-131.
15. Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly? JAMA. 1991;265:1720-1723.
16. Gurwitz JH, Goldberg RJ. Coronary thrombolysis for the elderly: is clinical practice really lagging behind evidence of benefit? JAMA. 1997;277:1723-1724.
17. Soumerai SB, McLaughlin TJ, Gurwitz JH, et al. Effect of local m edical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA. 1998;279:1358-1363.
18. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med. 1993;329:1271-1274.
19. Dicker RC, Ordin DL, Han LF, et al. Introducing the Medicare Quality of Care Surveillance System. Quality Resume No. 1. Baltimore, Md: Health Care Financing Administration; 1997.
20. Lomas J, Enkin M, Anderson GM, et al. Opinion leaders vs audit and feedback to implement practice guidelines: delivery after previous cesarean section. JAMA. 1991;265:2202-2207.
21. Stross JK, Bole GG. Evaluation of a continuing education program in rheumatoid arthritis. Arthritis Rheum. 1980;23:846-849.
22. Jencks SF, Daley J, Draper D, et al. Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA. 1988; 260:3611-3616.
23. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
24. Ludwigs U, Hulting J. Acute Physiology and Chronic Health Evaluation II scoring system in acute myocardial infarction: a prospective validation study. Crit Care Med. 1995;23:854-859.
25. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
26. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974.
27. Lambert-Huber DA, Ellerbeck EF, Wallace RG, et al. Quality of care indicators for patients with acute myocardial infarction: pilot validation of the indicators. Clin Performance Qual Health Care. 1994;2:219-222.
28. Davis DA, Thompson MA, Oxman AD, et al. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-705.
29. Soumerai SB, Avorn J. Principles of educational outreach ("Ac-ademic Detailing") to improve clinical decision making. JAMA. 1990;263:549-556.
30. Stross JK, Hiss RG, Watts CM, et al. Continuing education in pulmonary disease for primary-care physicians. Am Rev Respir Dis. 1983;27:739-746.
31. Soumerai SB, Avorn J. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. Health Soc. 1984;62:447-174.
32. Anderson FA, Wheeler HB, Goldberg RJ, et al. Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med. 1994;154:669-677.
33. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1,000 patients. Lancet. 1994;343:311-322.
34. Tversky A, Kahneman D. Judgement under uncertainty: heuristics and biases. Science. 1974;185:1124-1131.
35. Beyth RJ, Antani MR, Covinsky KE, et al. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med. 1996;11:721-728.
36. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med. 1997;126:593-598.